ABSTRACT
Objective To evaluate the clinical utility of automatable prediction models for increasing goals-of-care discussions among hospitalized patients at the end-of-life.
Materials and Methods We developed three Random Forest models and updated the Modified Hospital One-year Mortality Risk model: alternative models to predict one-year mortality (proxy for EOL status) using admission-time data. Admissions from July 2011-2016 were used for training and those from July 2017-2018 were used for temporal validation. We simulated alerts for admissions in the validation cohort and modelled alternative scenarios where alerts lead to code status orders (CSOs) in the EHR. We linked actual CSOs and calculated the expected risk difference (eRD), the number needed to benefit (NNB) and the net benefit (NB) of each model for the patient-centered outcome of a CSO among EOL hospitalizations.
Results Models had a C-statistic of 0.79-0.86 among unique patients. A CSO was documented during 2599 of 3773 hospitalizations at the EOL (68.9%). At a threshold that identified 10% of eligible admissions, the eRD ranged from 5.4% to 10.7% (NNB 5.4-10.9 alerts). Under usual care, a CSO had a 34% PPV for EOL status. Using this to inform the relative cost of FPs, only two models improved NB over usual care. A RF model with diagnostic predictors had the highest clinical utility by either measure, including in sensitivity analyses.
Discussion Automatable prediction models with acceptable temporal validity differed meaningfully in their expected ability to improve patient-centered outcomes over usual care.
Conclusion Decision-analysis should precede implementation of automated prediction models for improving palliative and EOL care outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by a clinician-investigator training grant (MR1-291226) funded jointly by the Fonds de Recherche du Quebec - Santé and the Ministère de la Santé et des Services Sociaux (Dr Taseen) and a clinician-investigator grant (CC-253453) from the Fonds de Recherche du Quebec - Santé (Dr Ethier). The Fonds de Recherche du Quebec - Santé and the Ministère de la Santé et des Services Sociaux had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the CIUSSS de l’Estrie - CHUS #2018-2478
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The hospitalization data underlying this article cannot be shared publicly due to regulations to protect patient privacy that are overseen by the IRB. All prediction model specifications, decision-analytic model specifications and the observed exchange rate estimates with various sampling procedures are included in the article and its online supplement. The source code for specific aspects of the study, like the data analysis or visualization source code in R or the two-stage bootstrap source code in C++, is available upon request to the corresponding author.
